NR 568 FINAL EXAM PREP | ADVANCED
PHARMACOLOGY QUESTIONS WITH ANSWERS &
RATIONALES NURSING STUDY GUIDE | VERSIONS A,
B AND C
Pass your psychiatric-mental health nurse practitioner advanced
pharmacology barrier with this ultimate 2026 NR 568 final exam
preparation package containing Versions A, B, and C. This
premium multi-version study guide features high-yield practice
questions paired with 100% verified answers and rigorous,
evidence-based clinical rationales. It is an indispensable resource
for graduate nursing students looking to master complex
psychotropic mechanisms, prescribing guidelines across the
lifespan, drug-drug interactions, and secure an A+ grade.
Question 1
An 80-year-old patient is prescribed a medication that undergoes significant first-pass
metabolism. Which age-related change would most likely require a dosage adjustment?
A. Increased hepatic blood flow
B. Decreased liver mass and blood flow, increasing oral bioavailability
C. Increased intestinal motility
D. Enhanced CYP450 enzyme activity
✅ Correct Answer: B. Decreased liver mass and blood flow, increasing oral
bioavailability
Rationale: Aging is associated with decreased liver mass and hepatic blood flow, reducing
first-pass metabolism . This increases the oral bioavailability of drugs with high first-pass
metabolism (e.g., propranolol, morphine, lidocaine). Lower doses may be needed to
prevent toxicity. CYP450 enzyme activity may also decline with age, further contributing to
reduced clearance. Hepatic clearance is reduced in older adults, and medications
metabolized by the liver require careful monitoring.
,Question 2
A patient with chronic kidney disease (CKD) is prescribed a medication that is primarily
excreted by the kidneys. The patient's estimated glomerular filtration rate (eGFR) is 25
mL/min/1.73m². Which dosing adjustment is most appropriate?
A. Administer the standard dose with extended intervals
B. Administer the standard dose at standard intervals
C. Increase the dose to achieve therapeutic levels
D. Administer the medication intravenously
✅ Correct Answer: A. Administer the standard dose with extended intervals
Rationale: In CKD, drugs that are renally excreted accumulate when given at standard
doses. Extending the dosing interval or reducing the dose maintains therapeutic levels
without toxicity. The maintenance dose is proportional to renal function (CrCl). The
loading dose may remain unchanged, but maintenance dose must be reduced. Drugs
requiring dose adjustment in CKD include aminoglycosides, vancomycin, lithium, digoxin,
and many beta-lactam antibiotics.
Question 3
A patient is receiving a drug that is a substrate for CYP3A4. The NP prescribes a strong
CYP3A4 inducer (rifampin). The expected effect on the substrate drug is:
A. Decreased plasma concentration and reduced therapeutic effect
B. Increased plasma concentration and toxicity
C. No change in plasma concentration
D. Increased half-life of the substrate drug
✅ Correct Answer: A. Decreased plasma concentration and reduced therapeutic
effect
Rationale: CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's Wort)
increase the metabolism of CYP3A4 substrates, reducing their plasma concentrations and
therapeutic effects. Dose increases may be necessary to maintain efficacy. The clinical
significance depends on the drug's therapeutic index and the degree of induction.
,Conversely, CYP3A4 inhibitors (ketoconazole, erythromycin, grapefruit juice) increase
substrate concentrations, leading to potential toxicity.
Question 4
A patient is prescribed a drug with a volume of distribution (Vd) of 100 L. This drug is
most likely:
A. Highly bound to plasma proteins and confined to the intravascular space
B. Extensively distributed into tissues and has a large Vd
C. A weak acid that is ionized in plasma
D. Primarily excreted unchanged in the urine
✅ Correct Answer: B. Extensively distributed into tissues and has a large Vd
Rationale: A Vd of 100 L indicates extensive tissue distribution, far exceeding total body
water (~42 L). Lipophilic drugs (e.g., digoxin, amiodarone) have large Vd. These drugs have
a long elimination half-life and may require loading doses to achieve therapeutic
concentrations. Vd is calculated as Dose / Plasma Concentration at time zero. Small Vd (<
10 L) suggests confinement to the intravascular space (e.g., warfarin, heparin).
Question 5
A patient with hypoalbuminemia is prescribed phenytoin. The NP should request which
laboratory test to accurately assess drug levels?
A. Free phenytoin level
B. Total phenytoin level
C. Serum albumin level
D. Liver function tests
✅ Correct Answer: A. Free phenytoin level
Rationale: Phenytoin is highly protein-bound (approximately 90%). In hypoalbuminemia,
protein binding is reduced, resulting in higher free (active) phenytoin levels despite normal
total levels. Toxicity can occur even when total levels are within the therapeutic range.
Therefore, free phenytoin levels should be monitored in patients with hypoalbuminemia,
, renal failure, or liver disease. The therapeutic range for free phenytoin is 1-2 mcg/mL.
Total phenytoin underestimates active drug in these patients.
Question 6
A patient is receiving a drug that is a weak base. In an acidic urine pH, the drug will be:
A. Ionized and excreted more rapidly
B. Non-ionized and reabsorbed
C. Bound to plasma proteins
D. Metabolized more slowly
✅ Correct Answer: A. Ionized and excreted more rapidly
Rationale: Weak bases are ionized (charged) in acidic environments and are trapped in
urine, promoting excretion (ion trapping). For weak bases, acidification of urine increases
the proportion of ionized drug that cannot cross lipid membranes and is excreted.
Conversely, alkalization of urine enhances excretion of weak acids (e.g., aspirin). The
Henderson-Hasselbalch equation describes this pH-dependent ionization. This principle is
used in treating drug overdoses (e.g., urinary alkalization for salicylate poisoning).
Question 7
A patient is started on a drug with a half-life of 12 hours. If the patient receives a
loading dose, when will steady state be achieved?
A. 24 hours (2 half-lives)
B. 48 hours (4 half-lives)
C. 60 hours (5 half-lives)
D. 12 hours (1 half-life)
✅ Correct Answer: C. 60 hours (5 half-lives)
Rationale: Steady state is achieved after approximately 4-5 half-lives regardless of the
loading dose. For a drug with t½ = 12 hours, steady state is reached in approximately 60
hours (5 × 12). A loading dose rapidly achieves therapeutic concentrations but does not
change the time to reach steady state. The loading dose is based on Vd and desired
PHARMACOLOGY QUESTIONS WITH ANSWERS &
RATIONALES NURSING STUDY GUIDE | VERSIONS A,
B AND C
Pass your psychiatric-mental health nurse practitioner advanced
pharmacology barrier with this ultimate 2026 NR 568 final exam
preparation package containing Versions A, B, and C. This
premium multi-version study guide features high-yield practice
questions paired with 100% verified answers and rigorous,
evidence-based clinical rationales. It is an indispensable resource
for graduate nursing students looking to master complex
psychotropic mechanisms, prescribing guidelines across the
lifespan, drug-drug interactions, and secure an A+ grade.
Question 1
An 80-year-old patient is prescribed a medication that undergoes significant first-pass
metabolism. Which age-related change would most likely require a dosage adjustment?
A. Increased hepatic blood flow
B. Decreased liver mass and blood flow, increasing oral bioavailability
C. Increased intestinal motility
D. Enhanced CYP450 enzyme activity
✅ Correct Answer: B. Decreased liver mass and blood flow, increasing oral
bioavailability
Rationale: Aging is associated with decreased liver mass and hepatic blood flow, reducing
first-pass metabolism . This increases the oral bioavailability of drugs with high first-pass
metabolism (e.g., propranolol, morphine, lidocaine). Lower doses may be needed to
prevent toxicity. CYP450 enzyme activity may also decline with age, further contributing to
reduced clearance. Hepatic clearance is reduced in older adults, and medications
metabolized by the liver require careful monitoring.
,Question 2
A patient with chronic kidney disease (CKD) is prescribed a medication that is primarily
excreted by the kidneys. The patient's estimated glomerular filtration rate (eGFR) is 25
mL/min/1.73m². Which dosing adjustment is most appropriate?
A. Administer the standard dose with extended intervals
B. Administer the standard dose at standard intervals
C. Increase the dose to achieve therapeutic levels
D. Administer the medication intravenously
✅ Correct Answer: A. Administer the standard dose with extended intervals
Rationale: In CKD, drugs that are renally excreted accumulate when given at standard
doses. Extending the dosing interval or reducing the dose maintains therapeutic levels
without toxicity. The maintenance dose is proportional to renal function (CrCl). The
loading dose may remain unchanged, but maintenance dose must be reduced. Drugs
requiring dose adjustment in CKD include aminoglycosides, vancomycin, lithium, digoxin,
and many beta-lactam antibiotics.
Question 3
A patient is receiving a drug that is a substrate for CYP3A4. The NP prescribes a strong
CYP3A4 inducer (rifampin). The expected effect on the substrate drug is:
A. Decreased plasma concentration and reduced therapeutic effect
B. Increased plasma concentration and toxicity
C. No change in plasma concentration
D. Increased half-life of the substrate drug
✅ Correct Answer: A. Decreased plasma concentration and reduced therapeutic
effect
Rationale: CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's Wort)
increase the metabolism of CYP3A4 substrates, reducing their plasma concentrations and
therapeutic effects. Dose increases may be necessary to maintain efficacy. The clinical
significance depends on the drug's therapeutic index and the degree of induction.
,Conversely, CYP3A4 inhibitors (ketoconazole, erythromycin, grapefruit juice) increase
substrate concentrations, leading to potential toxicity.
Question 4
A patient is prescribed a drug with a volume of distribution (Vd) of 100 L. This drug is
most likely:
A. Highly bound to plasma proteins and confined to the intravascular space
B. Extensively distributed into tissues and has a large Vd
C. A weak acid that is ionized in plasma
D. Primarily excreted unchanged in the urine
✅ Correct Answer: B. Extensively distributed into tissues and has a large Vd
Rationale: A Vd of 100 L indicates extensive tissue distribution, far exceeding total body
water (~42 L). Lipophilic drugs (e.g., digoxin, amiodarone) have large Vd. These drugs have
a long elimination half-life and may require loading doses to achieve therapeutic
concentrations. Vd is calculated as Dose / Plasma Concentration at time zero. Small Vd (<
10 L) suggests confinement to the intravascular space (e.g., warfarin, heparin).
Question 5
A patient with hypoalbuminemia is prescribed phenytoin. The NP should request which
laboratory test to accurately assess drug levels?
A. Free phenytoin level
B. Total phenytoin level
C. Serum albumin level
D. Liver function tests
✅ Correct Answer: A. Free phenytoin level
Rationale: Phenytoin is highly protein-bound (approximately 90%). In hypoalbuminemia,
protein binding is reduced, resulting in higher free (active) phenytoin levels despite normal
total levels. Toxicity can occur even when total levels are within the therapeutic range.
Therefore, free phenytoin levels should be monitored in patients with hypoalbuminemia,
, renal failure, or liver disease. The therapeutic range for free phenytoin is 1-2 mcg/mL.
Total phenytoin underestimates active drug in these patients.
Question 6
A patient is receiving a drug that is a weak base. In an acidic urine pH, the drug will be:
A. Ionized and excreted more rapidly
B. Non-ionized and reabsorbed
C. Bound to plasma proteins
D. Metabolized more slowly
✅ Correct Answer: A. Ionized and excreted more rapidly
Rationale: Weak bases are ionized (charged) in acidic environments and are trapped in
urine, promoting excretion (ion trapping). For weak bases, acidification of urine increases
the proportion of ionized drug that cannot cross lipid membranes and is excreted.
Conversely, alkalization of urine enhances excretion of weak acids (e.g., aspirin). The
Henderson-Hasselbalch equation describes this pH-dependent ionization. This principle is
used in treating drug overdoses (e.g., urinary alkalization for salicylate poisoning).
Question 7
A patient is started on a drug with a half-life of 12 hours. If the patient receives a
loading dose, when will steady state be achieved?
A. 24 hours (2 half-lives)
B. 48 hours (4 half-lives)
C. 60 hours (5 half-lives)
D. 12 hours (1 half-life)
✅ Correct Answer: C. 60 hours (5 half-lives)
Rationale: Steady state is achieved after approximately 4-5 half-lives regardless of the
loading dose. For a drug with t½ = 12 hours, steady state is reached in approximately 60
hours (5 × 12). A loading dose rapidly achieves therapeutic concentrations but does not
change the time to reach steady state. The loading dose is based on Vd and desired
